1. Home
  2. HCM vs GENI Comparison

HCM vs GENI Comparison

Compare HCM & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$15.10

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Logo Genius Sports Limited

GENI

Genius Sports Limited

N/A

Current Price

$5.77

Market Cap

2.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
HCM
GENI
Founded
2000
2016
Country
Hong Kong
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HCM
GENI
Price
$15.10
$5.77
Analyst Decision
Sell
Strong Buy
Analyst Count
1
17
Target Price
$13.75
$13.65
AVG Volume (30 Days)
23.0K
8.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$31.98
Revenue Next Year
$16.12
$26.04
P/E Ratio
$5.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.51
$5.70
52 Week High
$19.50
$13.73

Technical Indicators

Market Signals
Indicator
HCM
GENI
Relative Strength Index (RSI) 47.88 27.60
Support Level $14.69 N/A
Resistance Level $15.61 $11.74
Average True Range (ATR) 0.38 0.58
MACD -0.02 0.01
Stochastic Oscillator 43.40 5.29

Price Performance

Historical Comparison
HCM
GENI

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About GENI Genius Sports Limited

Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.

Share on Social Networks: